CC
PFE icon

Centiva Capital’s Pfizer PFE Stock Holding History

Centiva Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125M Buy
4,450,600
+2,029,500
+84% +$54M 0.92% 19
2025
Q4 		$60.3M Buy
2,421,100
+1,421,100
+142% +$35.8M 0.49% 42
2025
Q3 		$25.5M Buy
+1,000,000
New +$24.7M 0.24% 74
2024
Q4 		– Sell
-7,200
Closed -$208K – 2231
2024
Q3 		$208K Sell
7,200
-13,400
-65% -$391K ﹤0.01% 1802
2024
Q2 		$576K Buy
20,600
+19,000
+1,188% +$523K 0.01% 1066
2024
Q1 		$44.4K Sell
1,600
-36,000
-96% -$999K ﹤0.01% 1656
2023
Q4 		$1.08M Buy
37,600
+27,100
+258% +$819K 0.03% 585
2023
Q3 		$348K Buy
+10,500
New +$371K 0.01% 1117
2023
Q2 		– Sell
-10,200
Closed -$416K – 1908
2023
Q1 		$416K Sell
10,200
-46,900
-82% -$2.03M 0.01% 916
2022
Q4 		$2.93M Buy
57,100
+25,000
+78% +$1.2M 0.08% 250
2022
Q3 		$1.41M Buy
32,100
+10,400
+48% +$505K 0.03% 477
2022
Q2 		$1.14M Buy
21,700
+10,700
+97% +$545K 0.03% 551
2022
Q1 		$570K Sell
11,000
-337,300
-97% -$17.5M 0.01% 918
2021
Q4 		$20.6M Buy
348,300
+328,290
+1,641% +$16.3M 0.42% 41
2021
Q3 		$863K Buy
20,010
+18,010
+901% +$798K 0.05% 382
2021
Q2 		$78K Hold
2,000
– – ﹤0.01% 1277
2021
Q1 		$72K Sell
2,000
-360,500
-99% -$12.8M ﹤0.01% 1077
2020
Q4 		$13.3M Buy
362,500
+257,100
+244% +$9.43M 0.52% 34
2020
Q3 		$3.67M Hold
105,400
– – 0.24% 68
2020
Q2 		$3.27M Sell
105,400
-295,120
-74% -$10M 0.2% 69
2020
Q1 		$12.4M Buy
400,520
+105,400
+36% +$3.59M 0.56% 16
2019
Q4 		$11M Buy
+295,120
New +$10.5M 0.54% 37
2019
Q1 		– Sell
-75,045
Closed -$3.11M – 358
2018
Q4 		$3.11M Sell
75,045
-6,113
-8% -$254K 0.25% 57
2018
Q3 		$3.39M Buy
81,158
+73,253
+927% +$2.82M 0.29% 53
2018
Q2 		$273K Sell
7,905
-51,857
-87% -$1.77M 0.06% 70
2018
Q1 		$2.01M Buy
+59,762
New +$2.05M 0.48% 19

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Centiva Capital's PFE Position: Q1 2026 in Review

Centiva Capital increased its Pfizer (PFE) stake by 89% in Q1 2026, buying an estimated $6.47M and bringing the position to 515,495 shares worth $14.5M. The position accounts for 0.11% of the portfolio, ranked #135.

Centiva Capital first reported a position in PFE in Q3 2018 and has held it in 25 quarters since. The position peaked at $22.1M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Centiva Capital held 515,495 shares of Pfizer worth $14.5M as of Q1 2026.
  • Centiva Capital bought 243,137 Pfizer shares in Q1 2026, an estimated $6.47M.
  • Pfizer made up 0.11% of Centiva Capital's portfolio in Q1 2026, its #135 holding.
  • Centiva Capital first reported a position in Pfizer in Q3 2018 and has held it in 25 quarters since.
  • Centiva Capital's Pfizer position peaked at $22.1M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.